Bionomics Limited (OTCMKTS:BNOEF) Short Interest Update

Bionomics Limited (OTCMKTS:BNOEFGet Rating) saw a large growth in short interest during the month of August. As of August 31st, there was short interest totalling 432,700 shares, a growth of 8.3% from the August 15th total of 399,600 shares. Based on an average trading volume of 22,200 shares, the short-interest ratio is presently 19.5 days.

Bionomics Stock Performance

BNOEF opened at $0.04 on Monday. The stock has a fifty day moving average of $0.04 and a 200-day moving average of $0.04. Bionomics has a 12-month low of $0.03 and a 12-month high of $0.13.

About Bionomics

(Get Rating)

Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia and the United States. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which has completed phase 2 clinical trial for the treatment of social anxiety disorder and post-traumatic stress disorder.

Further Reading

Receive News & Ratings for Bionomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bionomics and related companies with MarketBeat.com's FREE daily email newsletter.